Cargando…
PAPAyA: a platform for breast cancer biomarker signature discovery, evaluation and assessment
BACKGROUND: The decision environment for cancer care is becoming increasingly complex due to the discovery and development of novel genomic tests that offer information regarding therapy response, prognosis and monitoring, in addition to traditional histopathology. There is, therefore, a need for tr...
Autores principales: | Janevski, Angel, Kamalakaran, Sitharthan, Banerjee, Nilanjana, Varadan, Vinay, Dimitrova, Nevenka |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2009
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2745694/ https://www.ncbi.nlm.nih.gov/pubmed/19761577 http://dx.doi.org/10.1186/1471-2105-10-S9-S7 |
Ejemplares similares
-
Effective normalization for copy number variation detection from whole genome sequencing
por: Janevski, Angel, et al.
Publicado: (2012) -
Major Chromosomal Breakpoint Intervals in Breast Cancer Co-Localize with Differentially Methylated Regions
por: Eric Tang, Man-Hung, et al.
Publicado: (2012) -
Identification of Tumor Suppressors and Oncogenes from Genomic and Epigenetic Features in Ovarian Cancer
por: Wrzeszczynski, Kazimierz O., et al.
Publicado: (2011) -
Discovery and characterization of medaka miRNA genes by next generation sequencing platform
por: Li, Sung-Chou, et al.
Publicado: (2010) -
Multi-dimensional discovery of biomarker and phenotype complexes
por: Payne, Philip RO, et al.
Publicado: (2010)